Shire acquires U.S. rights to Resolor
Shire PLC has acquired the rights to develop and market the gastrointestinal drug Resolor in the United States in an agreement with Janssen Pharmaceutica N.V. Shire said Tuesday that under the terms of the agreement, the U.S. rights to the Resolor trademark will be transferred to the company.